TT-034

· Tacere Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TT-034, covering 2016-11-30 to 2016-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C [Phase 1, Phase 2]